作者:Wilson Cunico、Claudia R.B. Gomes、Maria L.G. Ferreira、Thaís G. Ferreira、Danielle Cardinot、Marcus V.N. de Souza、Maria C.S. Lourenço
DOI:10.1016/j.ejmech.2011.01.004
日期:2011.3
as antibacterial agents against Mycobacterium tuberculosis H37Rv using the Alamar Blue susceptibility test and their activity expressed as the minimum inhibitory concentration (MIC) in μM. Two amino alcohols displayed significant activity when compared with first line drug ethambutol (EMB). Therefore this class of compounds could be a good starting point to develop new lead compounds in the treatment
由(2S,3S)Boc-苯丙氨酸环氧化物,哌啶胺和芳磺酰氯的反应以高收率合成了十三种新的羟乙胺。使用Alamar Blue药敏试验将这些化合物评估为抗结核分枝杆菌H37Rv的抗菌剂,并将其活性表示为以μM为单位的最小抑制浓度(MIC)。与一线药物乙胺丁醇(EMB)相比,两种氨基醇显示出显着的活性。因此,这类化合物可能是开发治疗结核病的新的先导化合物的良好起点。